《Drug Delivery》雜志的最新年發文量為119篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在藥學領域的學術影響力。
該刊聚焦于醫學-藥學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 約3.0個月 。
Drug Delivery 雜志發文統計
文章名稱引用次數
- Delivering CRISPR: a review of the challenges and approaches115
- Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease36
- Application of hyaluronic acid as carriers in drug delivery34
- Improving cellular uptake of therapeutic entities through interaction with components of cell membrane29
- Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy26
- Extracellular vesicle-mimetic nanovesicles transport LncRNA-H19 as competing endogenous RNA for the treatment of diabetic wounds25
- The challenges of oral drug delivery via nanocarriers21
- Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer20
- Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry20
- ENHANZE((R)) drug delivery technology: a novel approach to subcutaneous administration using recombinant human hyaluronidase 2019
國家/地區發文量
- CHINA MAINLAND321
- USA37
- Egypt30
- South Korea20
- Saudi Arabia12
- Iran10
- GERMANY (FED REP GER)9
- England8
- France8
- India8
